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Background: The use and determinants of rate versus rhythm control for management of atrial fibrillation (AF) in community practice have not 
been thoroughly defined.
Methods: The ORBIT-AF registry enrolled patients with AF from a broad range of practice settings and collected data on rate versus rhythm control.
Results: Of 9,559 patients enrolled, 6,540 (68%) were managed with rate control versus 3,019 (32%) with rhythm control. Patients managed with 
rate control were significantly older and more likely to have hypertension, sleep apnea, heart failure, chronic lung disease, prior CVA, GI bleeds and 
less likely to be living independently. (Table). Patients managed with rate control had lower EHRA symptom scores (ie, fewer symptoms), had slightly 
lower LVEF (54±12 vs 55± 12; p<.001), and larger left atrial diameters (4.8±0.9 vs 4.3±0.8 cm). Those managed with rhythm control were more 
likely to be treated by electrophysiologists and were less likely to have permanent AF. Anticoagulation was prescribed in 4,955 (76%) rate-controlled 
patients versus 1,915 (63%) rhythm-controlled patients (p<0.0001).
Conclusions: In US clinical practice, patients with AF are more commonly managed with a rate control strategy. Patients selected for rhythm 
control were younger, had less comorbidity, had less permanent AF and were more likely treated by electrophysiologists. 
Baseline characteristics of patients in the ORBIT-AF registry, stratified by AF management strategy.
Rate Control (n = 6,540) Rhythm Control (n = 3,019) P Value
Age, y 76 (68 - 83) 72 (63 - 79) <.001
Female 42% 42% 0.955
Type of AF <.001
First Detected / New Onset 5% 6%
Paroxysmal 41% 70%
Persistent 16% 16%
Permanent 38% 7%
Prior Cerebrovascular Event 17% 14% 0.001
Prior Gastrointestinal Bleeding 10% 8% 0.007
CHADS2 Score <.001
0 5% 10%
1 20% 27%
>2 75% 63%
EHRA Symptom Score <.001
No Symptoms 41% 31%
Mild 44% 47%
Severe 13% 19%
Disabling 1% 3%
Provider Specialty <.001
Cardiology 67% 61%
Electrophysiology 13% 22%
Internal Medicine 20% 18%
